Product image of No-Spa Forte (Drotaverine Hydrochloride) supplied by GNH India

No-Spa Forte

Active Ingredient:
Drotaverine Hydrochloride
Origin:
EU

No-Spa Forte (Drotaverine Hydrochloride)

Drotaverine Hydrochloride, the active ingredient in No-Spa Forte, is a phosphodiesterase inhibitor (smooth muscle relaxant) presented as an oral dosage form for oral use. It is employed to relieve smooth‑muscle spasm‑related pain in the gastrointestinal, urinary and biliary tracts, as well as dysmenorrhea.

GNH India supplies No‑Spa Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches, regulatory compliance and reliable logistics for cross‑border procurement.

Manufacturer / TM Owner

Opella Healthcare Commercial Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

No‑Spa Forte (drotaverine hydrochloride) is an antispasmodic that acts on smooth muscle to alleviate spasm‑related conditions.

  • Abdominal pain due to smooth muscle spasm: reduces intensity of pain by relaxing gastrointestinal smooth muscle.
  • Menstrual cramps (dysmenorrhea): eases uterine muscle contractions, decreasing cramp severity.
  • Biliary colic: relaxes biliary tract smooth muscle, facilitating bile flow and relieving pain.
  • Urinary tract spasm: diminishes bladder and ureteral smooth‑muscle tone, improving discomfort.

How It Works

  • Drotaverine hydrochloride inhibits phosphodiesterase‑4 enzymes, leading to an increase in intracellular cyclic AMP. Elevated cAMP reduces calcium influx in smooth‑muscle cells, causing relaxation of smooth muscle in the gastrointestinal, urinary, and biliary systems, as well as the uterus, thereby alleviating spasm‑related pain.

Side Effects

Adverse reactions to No‑Spa Forte are generally uncommon but may occur.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Dizziness: transient light‑headedness.
  • Headache: mild to moderate intensity.
  • Dry mouth: reduced salivation.
  • Hypotension: occasional drop in blood pressure.
  • Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects

  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Severe hypotension: marked blood‑pressure decline requiring medical attention.
  • Cardiac arrhythmias: irregular heart rhythm in susceptible individuals.
  • Hepatic dysfunction: elevated liver enzymes.
  • Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: unknown; weigh benefits against potential risks.
  • Renal impairment: monitor renal function as drug is excreted renally.
  • Hepatic impairment: dose adjustment may be required.
  • Concomitant antihypertensives: may enhance hypotensive effect.
  • Store at ambient temperature (below 25 °C): keep in original packaging, protect from moisture.

Avoid Interactions

Drug interaction assessment should include both major and moderate considerations.

Major Interactions (Avoid)

  • Co‑administration with other potent smooth‑muscle relaxants: risk of excessive hypotension.
  • Use with strong CYP3A4 inhibitors (if applicable): may increase plasma concentrations.
  • Combination with other phosphodiesterase inhibitors: heightened risk of cardiovascular effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: may require dose adjustment for blood‑pressure control.
  • Anticholinergic drugs: potential increase in dry‑mouth symptoms.
  • Diuretics: monitor electrolytes and blood pressure.
  • NSAIDs: watch for additive gastrointestinal irritation.
  • Alcohol: may potentiate dizziness or hypotension.

Frequently Asked Questions

No‑Spa Forte contains drotaverine hydrochloride and is prescribed to relieve smooth‑muscle spasm‑related pain. It is commonly used for abdominal discomfort caused by gastrointestinal spasm, menstrual cramps (dysmenorrhea), biliary colic, and urinary tract spasm.

Drotaverine hydrochloride blocks phosphodiesterase‑4, which raises intracellular cyclic AMP levels. The increased cAMP reduces calcium entry into smooth‑muscle cells, leading to relaxation of smooth muscle in the gastrointestinal, urinary, biliary tracts and uterus, thereby easing spasm‑related pain.

The appropriate dose of No‑Spa Forte is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and overall health. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for drotaverine hydrochloride in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies any potential risk to the fetus or infant, and after consultation with a qualified clinician.

To order No‑Spa Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with anticholinergic agents such as hyoscine, drotaverine offers smooth‑muscle relaxation without significant anticholinergic side effects like dry mouth or blurred vision. Its phosphodiesterase‑4 inhibition provides a distinct mechanism, making it useful when other antispasmodics are ineffective or poorly tolerated.

Store No‑Spa Forte at ambient temperature, preferably below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

No‑Spa Forte is administered orally. The tablet (or other oral dosage form) should be swallowed whole with a glass of water, unless the prescriber provides alternative instructions such as crushing for patients with swallowing difficulties.

Serious adverse events, although rare, include severe allergic reactions (rash, swelling, anaphylaxis), marked hypotension, cardiac arrhythmias, hepatic dysfunction and blood‑cell abnormalities. Patients should seek immediate medical attention if they experience any of these symptoms.

No‑Spa Forte should be avoided in individuals with known hypersensitivity to drotaverine or any excipients, in patients with severe uncontrolled hypotension, and in those for whom the risk–benefit profile is unfavorable, such as certain pregnant or lactating women without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Drotaverine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT